CDC: Cyclospora outbreak mystery solved

By ACSH Staff — Aug 01, 2013
Since June, the CDC has been notified of nearly 400 cases of infection by the parasite Cyclospora in seventeen states. At least twenty-two people have been hospitalized because of this outbreak.

Since June, the CDC has been notified of nearly 400 cases of infection by the parasite Cyclospora in seventeen states. At least twenty-two people have been hospitalized because of this outbreak.

Type 2 diabetes on the rise in New York

By ACSH Staff — Aug 01, 2013
According to a new report released by the New York City Health Department over the past ten years, the number of New Yorkers with type 2 diabetes has increased from eight percent to about 11 percent. This number is higher than the national average of 9.5 percent.

According to a new report released by the New York City Health Department over the past ten years, the number of New Yorkers with type 2 diabetes has increased from eight percent to about 11 percent. This number is higher than the national average of 9.5 percent.

Qsymia risk management system used to to prevent fetal harm

By ACSH Staff — Jul 31, 2013
Qsymia is an FDA approved drug used to manage weight in obese and some overweight adults who may have weight-related medical problems such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia). The drug

Qsymia is an FDA approved drug used to manage weight in obese and some overweight adults who may have weight-related medical problems such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia). The drug

Antibiotics and the FDA: will the agency reboot its policies?

By ACSH Staff — Jul 31, 2013
Former vice president of infectious disease research at Wyeth and ACSH advisor Dr. David Shlaes knows a thing or two about dealing with the FDA, and its misguided policies regarding approval of new antibiotics.

Former vice president of infectious disease research at Wyeth and ACSH advisor Dr. David Shlaes knows a thing or two about dealing with the FDA, and its misguided policies regarding approval of new antibiotics.

Treatment of some breast lesions may wait

By ACSH Staff — Jul 31, 2013
Today we have an example of some breast lesions atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) that may require such a redefinition under some circumstances.

Today we have an example of some breast lesions atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) that may require such a redefinition under some circumstances.

Bloomberg s soda ban defeated again

By ACSH Staff — Jul 31, 2013
New York s attempted soda ban is back in the news today, but this may be the last we hear of it. A New York appeals court officially ruled yesterday that the ban was unconstitutional. The panel of judges declared that

New York s attempted soda ban is back in the news today, but this may be the last we hear of it. A New York appeals court officially ruled yesterday that the ban was unconstitutional. The panel of judges declared that

GMO labeling hearing in NYC

By ACSH Staff — Jul 30, 2013
There has been heated debate over the last few years regarding the labeling of GMOs in food. Several states have passed or have tried to pass laws requiring the labeling of these foods.

There has been heated debate over the last few years regarding the labeling of GMOs in food. Several states have passed or have tried to pass laws requiring the labeling of these foods.

Rethinking the definition of cancer and its treatments

By ACSH Staff — Jul 30, 2013
According to the recommendations made in a new report published in the July 29, 2013, issue of JAMA, more needs to be done to redefine the word cancer and the subsequent approaches to cancer treatments.

According to the recommendations made in a new report published in the July 29, 2013, issue of JAMA, more needs to be done to redefine the word cancer and the subsequent approaches to cancer treatments.

New recommendation by the USPSTF for high-risk smokers

By ACSH Staff — Jul 30, 2013
Earlier this year, the American College of Chest Physicians issued guidelines stating that doctors should consider low-dose CT screening for individuals at high risk for lung cancer. Now the US Preventive Services Task Force (USPSTF) is following in their footsteps

Earlier this year, the American College of Chest Physicians issued guidelines stating that doctors should consider low-dose CT screening for individuals at high risk for lung cancer. Now the US Preventive Services Task Force (USPSTF) is following in their footsteps